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Polyclonal antibodies raised against isolated subunit V from beef heart cytochrome oxidase or against he intact enzyme 
increase its apparent affinity for the substrate cytochrome c at the high-affinity site while diminishing the turnover at 
that site. At the low-affinity site the major action of both types of antibody is to reduce the apparent affinity for cyto- 
chrome c. At high ionic strengths the kinetic effect of anti-subunit V is very small although it still binds to the enzyme. 
The results are interpreted in terms of a model for the enzyme in which antibodies can modulate cytochrome oxidase 
kinetics by affecting the binding of cytochrome c, even if the antibody-binding site is on a subunit not directly involved 
in substrate binding. 
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1. INTRODUCTION 
Eukaryotic ytochrome oxidase comprises both 
mitochondrially synthesized and cytoplasmically 
synthesized polypeptide subunits (see, e.g. [1]). 
The mitochondrially encoded subunits appear to 
contain all the catalytic entres of the enzyme. The 
nuclear-encoded subunits have not yet been assign- 
ed functions, although it is speculated that they 
may be involved in control of the enzyme by in- 
tramitochondrial or cytoplasmic factors [2,3]. 
Antibodies directed against either the whole en- 
zyme [4,5] or specific subunits [6,8] can, if they 
modify the catalytic activity of the oxidase, be used 
to obtain information about he location and func- 
tional interrelationships of the several subunits. In 
1970 Mochan et al. [4] were able to show that anti- 
oxidase could bind at a site that interfered with the 
reaction of the substrate cytochrome c. The an- 
tibody behaved as a competitive inhibitor towards 
cytochrome c at high concentrations of c, but acted 
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as a mixed inhibitor at lower c concentrations, 
resulting in nonlinear Lineweaver-Burk plots. 
However, the maximal inhibition was only 
50-60°7o. More recently anti-oxidase preparations 
have been obtained which show increased in- 
hibitory effects [5,8]. Thus, we were able to show 
that a preparation of anti-oxidase blocked not only 
the reaction with cytochrome c, probably by in- 
teraction with the putative cytochrome c-binding 
site on the enzyme's subunit II, but also that with 
the non-physiological reductant TMPD [9]. This 
suggested that antibody binding could affect in- 
tramolecular electron-transfer vents, including 
those which are presumed to occur between redox 
centres in subunit I [9,10]. 
Indirect effects of antibody binding have also 
been observed using monoclonal antibodies 
prepared against subunit IV of the oxidase [11]. 
These monoclonals react specifically with epitopes 
on the fourth subunit hat extend into the matrix 
phase of the mitochondrion. One monoclonal in- 
creases the turnover of the enzyme, while the other 
decreases turnover. In neither case, however, can 
the observed effects be interpreted as a simple 
kinetic effect on one of the enzyme parameters. 
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Ant ibody prepared against the nuclear-encoded 
subunit V also modulates the kinetics in a 
characteristic way [12-14]. Not only is the binding 
dependent upon the presence of  reduced 
cytochrome c [12,13], and specific for an epitope 
exposed on the N (matrix) face of  the membrane, 
but the antibody also affects the catalytic 
behaviour of  the enzyme in an unusual manner 
[14]. It induces the appearance of  biphasicity in the 
Hofstee plot of  v/[c] vs v, mimicking the 
behaviour usually seen only at low ionic strengths 
[14]. This effect can therefore be analysed as in- 
volving the high-affinity phase of  the oxidase reac- 
tion; whether it is necessary to postulate other in- 
fluences of  the antibody is uncertain. 
To enable these and similar results to be inter- 
preted satisfactorily, it was therefore necessary to 
extend the previous study to include a range of  
ionic strengths and to examine the influence of  
ionic strength on antibody binding and on the ef- 
fect o f  anti-subunit V on the enzyme kinetics. At 
the same time we have compared the action of  the 
specific anti-V antibody with that of  the anti- 
oxidase. We show that antibody binding to a 
nuclear-encoded subunit which is not directly in- 
volved in the formation of  the enzyme-substrate 
complex can inhibit activity by decreasing the rate 
o f  product release. Such antibody-induced confor- 
mationai changes may mimic genuine physiological 
control  mechanisms in cytochrome oxidase acting 
via the nuclear subunits. 
2. MATERIALS  AND METHODS 
Cytochrome oxidase was prepared from beef heart according 
to Kuboyama et al. [ 15]. Anti-subunit V from rabbits was a kind 
gift from Dr Jo A. Freedman, and had been prepared as de- 
scribed [13]. Its specificity was checked by Western Blot analysis 
as in [9,14]. Anti-oxidase was prepared from rabbit serum as 
described [14]. Cytochrome oxidase activity was measured 
either spectrophotometricaily ccording to Smith and Conrad 
[16], using an Aminco DW-2 spectrophotometer at the dual- 
wavelength pair 550-540 nm or polarographically in the 
presence of ascorbate and TMPD as in [14] using a Clark elec- 
trode (Yellow Springs Instrument). Preincubation of enzyme 
with the indicated amount of antibodies was carried out as 
described in [14] and the figure legends. 
Cytochrome c was Sigma type VI from horse heart. It was 
reduced when necessary with sodium ascorbate, removing the 
excess reductant on a Sephadex G-25 column. TMPD 
(N,N,N ',N '-tetramethyl-p-phenylenediamine dihydrochloride) 
and sodium ascorbate were also Sigma products. Lauryl-~-D- 
maltoside was obtained from Calbiochem. 
3. RESULTS 
Incubation of  cytochrome c oxidase with an- 
t ibody prepared against subunit V induces inhibi- 
t ion of  the catalytic activity in the isolated enzyme, 
as previously reported [14]. However, the action is 
not complete. Fig. 1 shows the inhibitory effect ob- 
tained using a spectrophotometric assay at varying 
antibody-antigen ratios and a fixed level o f  
substrate at a low pH to optimize the turnover ac- 
cording to Wilms et al. [17]. An antibody-antigen 
ratio o f  100 achieves 50°70 inhibition of  the reaction 
(with an apparent Ki equivalent to an Ab/Ag  ratio 
o f  about 40) and increasing this ratio to 900 has no 
further effect. The antibody-enzyme complex is 
therefore catalytically active. However, the degree 
of  inhibition is significantly greater than that of  
other polyclonal anti-subunit V preparations 
assayed under identical conditions [12]. As dif- 
ferent preparations also show distinctly different 
antigen binding characteristics [13] it is clear that 
subunit V must expose more than one antigenic 
determinant in the holoenzyme. 
The titration with antibody illustrated in fig. 1 
was carried out at a single substrate concentration. 
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Fig.l. Anti-subunit V 7-globulin as a partial inhibitor of 
cytochrome oxidase: spectrophotometric asay. The response of 
the enzyme to varying amounts of antibody was monitored 
spectrophotometrically by following cytochrome c oxidation at 
the indicated Ab/Ag ratios. The medium contained 27 /~M 
ferrocytochrome c in 100 mM potassium phosphate buffer 
(pH 6.0) containing 0.5 mM EDTA and 0.05% Tween-80. The 
reaction induced by addition of 5.4 nM cytochrome aa3 was 
monitored at 550-540 nm. Error bars are + 1 SD (n= 3). 
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increasing the Ab/Ag ratio from 250:1 to 500:1 has 
no effect at any cytochrome c concentration [14]. 
At saturating concentrations of cytochrome c the 
system presumably contains a triple complex of 
antibody-enzyme-cyt.c, which is turning over at 
half the rate of the usual enzyme-cyt.c complex. 
This may reflect he rate of either a decrease in pro- 
duct dissociation or an internal electron-transfer 
step, or a combination of both. Whichever process 
is modified, it is seen both at high [14] and low 
(fig. 1) pH, and thus over a substantial range of ac- 
tivities [17]. 
When the ionic strength is reduced to 5 mM 
phosphate and the assay is carried out polaro- 
graphically the control enzyme shows the 
characteristic biphasic behaviour towards cyto- 
chrome c concentration (fig.2A). This behaviour 
has been interpreted in terms of 'high- & low- 
affinity' binding sites for the substrate [18,19] but 
it may be noted the phenomenon is also capable of 
several other types of interpretation [20,21]. 
Fig.2A shows that upon addition of anti-subunit 
V, the enzyme is always inhibited, but that the pat- 
tern of inhibition differs in the two phases of the 
plot. In the 'high-affinity' region the action of the 
antibody appears to be non-competitive, reducing 
Vma~ without affecting Kin; in the 'low-affinity' 
region its action is competitive (or 'pseudo- 
competitive'; cf. [14,22]). 
Fig.2B shows the corresponding Hofstee plots 
for the inhibition both by anti-subunit V and by an 
anti-oxidase preparation obtained at much higher 
ionic strengths. Under these conditions using the 
polarographic assay the anti-V antibody has almost 
no inhibitory action (fig.2B: note coincident points 
for the upper curve). Anti-oxidase, on the other 
hand, remains an effective inhibitor at these high 
ionic strengths, and also shows a tendency to in- 
duce biphasic patterns of response to cytochrome 
c. The results shown in fig.2A,B for anti-subunit V
are consistent with the previous report [14] that the 
inhibitor induced the appearance of biphasicity in 
the Hofstee plots under conditions of intermediate 
ionic strength (50 mM phosphate) in which the 
control enzyme behaves monophasically (see fig.5 
of [14]). 
The failure of the anti-subunit V antibody to 
secure appreciable inhibition at ionic strengths of 
150 mM phosphate or above is not due to a failure 
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Fig.2. Anti-subunit V 7-globulin as an inhibitor of cytochrome 
oxidase at low and high ionic strengths: polarographic assay. 
(A) Eadie-Hofstee plot of the activity of cytochrome oxidase in 
the presence and absence of anti-subunit V: low ionic strength 
conditions. Cytochrome c concentrations were varied from 67 
nM to 0.09 mM in a medium containing 5 mM potassium 
phosphate (pH 7.4), 0.1% lauryl maitoside, 5 mM sodium 
ascorbate, 0.2 mM TMPD and 25 nM cytochrome aa3, 
preincubated in the presence (m) and absence (Q) of anti- 
subunit V antibody (Ab/Ag ratio = 200:1). 30°C (Inset) 
Expanded plot of the low-affinity region. The lines drawn 
represent approximate asymptotes for the low- and high-affinity 
regions of activity. (B) Eadie-Hofstee plot of the activity of 
cytochrome oxidase in the presence ofanti-subunit V and anti- 
oxidase: high ionic strength conditions. The reaction medium 
was 150 mM potassium phosphate (pH 7.4) containing 0.1°70 
lauryl maitoside and cytochrome c concentrations upto 0.15 
mM. Other conditions as in A. Control preincubations were 
carried out in the absence ofantibody ([]). The Ab/Ag ratio for 
anti-subunit V antibody was 200:1 (m); and for anti-oxidase, 
75:1 (&). 
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This can be seen by comparing the inhibitions een 
when the enzyme is incubated with antibody at dif- 
ferent ionic strengths but assayed at a common (50 
mM) ionic strength (table 1). Such a method can be 
employed because the binding and release of an- 
tibody take time [14] and in consequence the initial 
level of  inhibition seen in the assay reflects the in- 
cubation rather than the assay conditions. Approx. 
2007o inhibition is obtained in each case. ELISA 
assays carried out at comparatively high ionic 
strengths (cf. [13]) also do not show evidence of ap- 
preciable salt-induced issociation of the enzyme- 
antibody complex (Freedman, personal com- 
munication). 
This behaviour towards the enzyme of the an- 
tibody raised against subunit V contrasts with the 
behaviour of the anti-oxidase. The latter affects 
both Vmax and Km when tested at high (fig.2B) and 
at low ionic strengths (not shown). This polyclonal 
preparation of anti-oxidase, like our current anti- 
subunit V preparation, increases the biphasicity 
seen at intermediate ionic strengths. The anti- 
oxidase also induces a biphasicity in the high ionic 
strength medium where the anti-subunit V is 
without effect. It is clear that the anti-oxidase con- 
tains components capable of modulating the 
kinetics of the enzyme like the anti-subunit V, but 
in addition contains components hat react directly 
with the catalytic subunits I and II, directly 
modulating the binding of cytochrome c and the in- 
ternal electron transfer processes. 
Table 1 
Effect of preincubation at different ionic strengths upon 
inhibition of cytochrome oxidase by anti-subunit V 
the 
Ionic strength Turnover (electrons/aa3 per s) 
of preincubation Control + Anti-V 
5 mM phosphate 58.0 ± 0.6 43.6 ± 4.6 
50 mM phosphate 59.0 ± 0.9 45.7 ± 2.7 
150 mM phosphate 57.6 ± 2.2 49.4 ± 1.6 
Enzyme was preincubated with anti-subunit V y-globulin at a 
ratio of 275:1 Ab/Ag in the indicated phosphate buffer 
concentrations for 15 min. It was then assayed spectrophoto- 
metrically in 50 mM potassium phosphate buffer (pH 7,4) 
containing 0.075% lauryl maltoside at 30°C. 9 #M 
ferrocytochrome c was used as substrate with 4 nM (final 
concentration) cytochrome aa~ as enzyme. Rates are shown as 
means ± 1 standard eviation (n = 3) 
4. DISCUSSION 
As pointed out by Gai et al. [11], the differential 
action of antibodies on the two kinetic phases of 
cytochrome c oxidation supports the idea of 
separate binding sites or at least separate reaction 
types for cytochrome c in the high- and low-affinity 
regions, as outlined in the model of Brooks and 
Nicholls [23]. Anti-subunit V apparemly binds to 
subunit V at the N (matrix) face of the enzyme 
[12,13] and in so doing it reduces the off  constant 
for cytochrome c bound at the high affinity site. It 
consequently renders the kinetic profile at in- 
termediate ionic strength similar to that seen for 
the control enzyme at a lower ionic strength. We 
propose that the bound cytochrome c is less readily 
dissociated following oxidation; the entry of fur- 
ther reducing equivalents into the system is slowed. 
At low ionic strength two phases are seen in both 
the control and the inhibited enzyme systems. The 
effects of anti-subunit V can be explained using 
either one of two possible models. The first such 
model assumes that the low-affinity cytochrome c 
binding site increases the flux through the enzyme 
by enhancing the dissociation rate of the catalytic 
cytochrome c bound at the high-affinity site 
[20,24]. The alternative assumes that cytochrome c 
at the low-affinity site increases the reduction rate 
of tightly bound cytochrome c [23]. In both models 
product dissociation limits Vm~x at low ionic 
strengths and low concentrations of cytochrome c 
[19,23]. However, the turnover at high levels of c 
(Vmx at the low-affinity site) is largely limited by 
the speed of internal electron transfer, as it is in- 
dependent of ionic strength (see [23,24]. 
The main effect of anti-subunit V in the high- 
affinity region is to decrease Vmax. However, there 
is no effect on Vm~x in the low-affinity region as the 
increase in product dissociation or reduction rate 
caused by the binding of the second molecule of 
cytochrome c offsets the decrease caused by the an- 
tibody. In order to overcome the antibody effect, 
however, it is necessary to have a higher concentra- 
tion of cytochrome c to interact with the low- 
affinity site (or a higher 'occupancy' at the site). 
This accounts for the increase in low-affinity Km 
observed after antibody binding. Thus the complex 
kinetic effects of anti-subunit V binding can all be 
explained by assuming that it induces a conforma- 
tional change that decreases the dissociation rate of 
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Fig.3. A schematic representation of the arrangement of the 
subunits of the oxidase in the mitochondrial membrane and the 
sites of action of the effective antibodies. 
ferricytochrome c from the high-affinity site on 
subunit II. Such a long range effect could be com- 
municated irectly from subunit V to subunit II as 
cross-linking experiments show the two subunits to 
be within 11 .~ of each other [25]. 
A very similar explanation can be advanced to 
account for the kinetic action of the two types of 
monoclonal antibodies prepared against subunit IV 
[11]. Monoclonal QA4 inhibits the enzyme by in- 
creasing the Km seen in the high-affinity region. It 
binds on the 'N'  (matrix) side, as does anti-subunit 
V; its action therefore also reflects a transmem- 
branous effect. Such an effect can possibly be exer- 
ted through the subunit IV-subunit II interface, 
with a consequent destabilization of the tight com- 
plex. Monoclonal QA4 also increases the Km of the 
low-affinity reaction; this could be a result of a 
change in the accessibility of cyt. c at the high- 
affinity site towards the second molecule of cyt. c. 
The monoclonal QA4/C4 actually increases the ap- 
parent Vm~x at the high-affinity site by a factor of 
more than two. It does not significantly alter the 
high-affinity Km nor does it have any effect on Vm~x 
in the low-affinity region (though there is a slight 
increase of Km). In an analogous way to the effect 
postulated for anti-subunit V, QA4/C4 could in- 
crease the high affinity Vmax by increasing the rate 
of product dissociation. Alternatively its action 
could be envisaged as increasing the accessibility of 
bound cyt. c to the reductant TMPD, one of the 
usual rate-limiting events that determines the 
magnitude of Vmax at the high-affinity site [23]. 
Fig.3 summarizes our present picture of the rela- 
tionships between the various subunits involved in 
catalysing and controlling the turnover of this en- 
zyme. Events at the matrix (N) face of the oxidase 
can modify its behaviour towards the substrate 
cytochrome c at the cytosolic (P) face. Such 
modifications may include changes in the reactivity 
and dissociability of cytochrome c at the high- 
affinity site on subunit II. The antibodies thus 
mimic the action of some of the more physiological 
influences, such as the levels of metabolites and 
nucleotides on the two sides of the inner mitochon- 
drial membrane, that have been postulated [2,3] to 
control cytochrome oxidase. 
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